Clinical Trials Index

Back

STUDY CODE CLINICALTRIALS.GOV EUDRACT PUBLICATIONS
PHASE I Studies
BIA-2093-101 NCT02171195 - DOI:10.2165/00126839-200304050-00001
BIA-2093-102 NCT02171234 - DOI: 10.1177/0091270004267591
BIA-2093-103 NCT02170649 - DOI: 10.2165/00126839- 200506040-00002
BIA-2093-104 NCT01678976 - -
BIA-2093-105 NCT02172755 - DOI: 10.1177/0091270005279364 DOI: 10.1002/bdd.549
BIA-2093-106 NCT01878578 - -
BIA-2093-107 NCT02172742 - DOI: 10.1111/j.1472- 8206.2009.00691.x
BIA-2093-108 NCT02287415 - DOI: 10.1016/j.clinthera.2010.01.014
BIA-2093-109 NCT02279667 - DOI: 10.2165/00126839- 200506050-00001
BIA-2093-110 NCT01679002 - DOI: 10.1111/epi.12242
BIA-2093-111 NCT02281526 - DOI: 10.1007/s00228-007-0414-1
BIA-2093-112 NCT02281422 - DOI 10.5414/CPP46119
BIA-2093-113 NCT01879345 2004-002994-22 -
BIA-2093-114 NCT02281448 2004-004490-28 DOI: 10.1016/j.eplepsyres.2013.02.020
BIA-2093-115 NCT02281591 2005-006016-22 -
BIA-2093-116 NCT02283788 - DOI: 10.1177/0091270010391789
BIA-2093-117 NCT02288312 2007-000714-36 DOI: 10.2165/0126839- 200809060-00007
BIA-2093-118 NCT01879332 - -
BIA-2093-119 NCT02283801 - DOI: 10.1111/j.1600- 0404.2009.01233.x
BIA-2093-120 NCT02283814 - DOI: 10.1185/03007991003740861
BIA-2093-121 NCT02283827 - DOI: 10.1111/j.1528- 1167.2012.03519.x
BIA-2093-122 NCT02283840 - DOI:10.4172/jbb.1000014
BIA-2093-123 NCT02284828 - DOI: 10.1016/j.yebeh.2010.04.022
BIA-2093-124 NCT00987558 2009-012211-18 DOI: 10.1016/j.eplepsyres.2013.04.009
BIA-2093-125 NCT00971295 2007-003953-94 DOI 10.5414/CPP47255
BIA-2093-126 NCT02777671 2007-003954-27 -
BIA-2093-127 NCT00900237 2008-004800-30 DOI: 10.1111/j.1528-1167.2012.03595.x
BIA-2093-128 NCT00898560 2007-006529-28 DOI: 10.1016/j.eplepsyres.2013.02.020
BIA-2093-129 NCT02284854 2009-012550-21 DOI: 10.1111/j.1528-1167.2012.03519.x
BIA-2093-130 NCT02284880 2010-022478-15 DOI: 10.1007/s40268-013-0016-6
BIA-2093-131 NCT03116321 - -
BIA-2093-132   2018-001484-23  
PHASE II Studies
BIA-2093-201 NCT02170077 - DOI: 10.1111/j.1528-1167.2007.00984.x
BIA-2093-202 NCT02170064 - DOI: 10.1177/0091270008319706
BIA-2093-203 NCT01822678 2005-002131-27 DOI: 10.1016/j.jad.2014.11.013
BIA-2093-204 NCT01824602 2005-002133-13 DOI: 10.1016/j.jad.2014.11.013
BIA-2093-205 NCT01825837 2005-002134-35 DOI: 10.1016/j.jad.2014.11.013
BIA-2093-206 NCT00980746 2007-002461-12 -
BIA-2093-207 NCT00981227 2007-002473-31 -
BIA-2093-208 NCT01527513 2008-005606-39 -
BIA-2093-209 NCT01820559 2008-003736-38 -
BIA-2093-210 NCT01820585 2008-003557-32 -
BIA-2093-211 - 2012-001091-11 -
BIA-2093-211/EXT - 2016-001072-29 -
BIA-2093-212 NCT02021461 2012-003137-41 -
BIA-2093-213 - 2018-002747-29 -
PHASE III Studies
BIA-2093-301 NCT00957684 2004-000766-12 DOI: 10.1111/j.1528-1167.2008.01946.x
DOI: 10.1111/j.1528-1167.2010.02660.x
DOI: 10.1016/j.eplepsyres.2011.05.013
DOI: 10.2165/11596290-000000000-00000
DOI: 10.1111/j.1528-1167.2012.03605.x
BIA-2093-302 NCT00957047 2004-000483-27 DOI: 10.1016/j.eplepsyres.2010.01.014
DOI: 10.1016/j.eplepsyres.2012.07.014
DOI: 10.2165/11596290-000000000-00000
DOI: 10.1111/j.1528-1167.2012.03605.x
BIA-2093-303 NCT00957372 2004-001748-66 DOI: 10.1111/j.1600-0404.2009.01218.x
DOI: 10.2165/11596290-000000000-00000
DOI: 10.1111/j.1528-1167.2012.03605.x
BIA-2093-304 NCT00988429 2008-002455-25 DOI: 10.1016/j.yebeh.2015.09.018
DOI: 10.1111/epi.12894
BIA-2093-305 NCT00988156 2007-001887-55 DOI: https://doi.org/10.1016/j.yebeh.2020.106962
BIA-2093-307 NCT01129960 2010-019100-23 -
BIA-2093-308 NCT01124097 2010-019101-42 -
BIA-2093-311 NCT01162460 2009-011135-13 DOI: 10.1111/epi.13993
BIA-2093-311/EXT NCT02484001 2015-001243-36 https://doi.org/10.1111/epi.16666
PHASE IV Studies
BIA-2093-401 NCT01422720 2009-012587-14 DOI: 10.1007/s40266-018-0602-y
BIA-2093-403 NCT01532726 - doi: 10.1111/ane.12734

STUDY CODE CLINICALTRIALS.GOV EUDRACT PUBLICATIONS
PHASE I Studies
BIA-91067-101 NCT01520727 2007-004161-18 DOI: 10.1007/s40262-012-0024-7
BIA-91067-102 NCT02071810 2008-001288-12 DOI: 10.1111/bcp.12081
BIA-91067-103 NCT01515891 - -
BIA-91067-104 NCT02071823 - DOI: 10.1007/s40262-012-0024-7
BIA-91067-105 NCT02092168 2008-005145-35 -
BIA-91067-106 NCT02101190 2009-015899-10 DOI: 10.1007/s00228-013-1602-9
BIA-91067-107 NCT02169895 - -
BIA-91067-108 NCT02169479 - -
BIA-91067-109 NCT02169466 2008-003289-25 -
BIA-91067-110 NCT02169453 - -
BIA-91067-111 NCT01532115 2010-019240-40 DOI: 10.1002/cpdd.188
BIA-91067-112 NCT01532128 2009-016073-15 -
BIA-91067-113 NCT01532141 2009-016074-32 -
BIA-91067-114 NCT01519284 2009-014549-94 -
BIA-91067-115 NCT01536366 2009-011449-24 -
BIA-91067-116 NCT02169440 2009-010765-24 -
BIA-91067-117 NCT01533077 - -
BIA-91067-118 NCT01533116 - DOI: 10.1111/bcp.13156
BIA-91067-119 NCT02305277 2014-000267-41 -
BIA-91067-120 NCT02305316 2013-004775-12 -
BIA-91067-121 NCT02305329 2014-000225-21 -
BIA-91067-122 NCT02169427 2011-000298-30 -
BIA-91067-123 NCT02169414 2009-018138-13 DOI: 10.1111/bcp.13156
BIA-91067-124 NCT02170376 2011-000173-31 DOI: 10.1007/s00228-014-1701-2
BIA-91067-125 NCT02305017 2013‐003871‐37 -
BIA-91067-126 NCT01520987 - DOI: 10.1002/cpdd.213
BIA-91067-127 NCT02305030 2014-000205-13 -
BIA-91067-128 NCT03116308 2014-001626-15 -
BIA-91067-129 NCT03116295 2017-000857-37 -
BIA-91067-130 NCT03119194 2016-004454-15 -
BIA-91067-131 NCT04265027 2017-004680-13 -
BIA-91067-132 NCT03820037 2018-004748-45 -
PHASE II Studies
BIA-91067-201 NCT01568034 2008-003869-72 DOI: 10.1002/cpdd.217
BIA-91067-202 NCT01568047 2009-012897-12 DOI: 10.1111/ene.12666
PHASE III Studies
BIA-91067-301 NCT01568073 2010-021860-13 DOI: 10.1016/S1474-4422(15)00336-1
DOI: 10.3233/JPD-191593
BIA-91067-302 NCT01227655 2010-022366-27 DOI: 10.1001/jamaneurol.2016.4703
DOI: 10.3233/JPD-191593
BIA-91067-303 NCT04978597 2020-005011-52 -
PHASE IV Studies
BIA-OPC-401 NCT02847442 2016-002391-27 DOI: 10.1186/s40035-020-00187-1
BIA-91067-402 NCT03959540 - -
BIA-91067-403 NCT04990284 2020-002754-24 -
BIA-91067-404 NCT04990284 2020-001175-32 -
BIA-91067-405 NCT04986995 2020-001176-15 -

STUDY CODE CLINICALTRIALS.GOV EUDRACT PUBLICATIONS
PHASE I Studies
BIA-51058-101 NCT02151994 2010-023490-19 https://doi.org/10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A3816
BIA-51058-102 NCT04991155 2015-001951-65 -
BIA-51058-104 NCT04991181 2015-002407-28 -
BIA-51058-105 NCT04991194 2015-003682-28 -
BIA-51058-106 NCT04675944 2017-000245-43 -
BIA-51058-107 NCT04991207 2015-004350-17 https://journal.chestnet.org/article/S0012-3692(20)31303-9/fulltext
BIA-51058-108 NCT04994860 2017-000224-99 https://erj.ersjournals.com/content/56/suppl_64/1458
BIA-51058-109 NCT04994119 2015-004351-49 https://journal.chestnet.org/article/S0012-3692(20)34114-3/fulltext
BIA-51058-110 - 2020‐000224‐18 -
BIA-51058-111 - 2017-002807-93 -
BIA-51058-113 - 2017-003518-23 -
BIA-51058-114 - 2017-003519-20 -
BIA-51058-115 NCT03489005 2017-001682-25 https://doi.org/10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A3815
BIA-51058-116 NCT03708146 2018-000113-20 -
BIA-51058-117 - - -
BIA-51058-118 - - -
BIA-51058-119 NCT04069130 2018-003995-11 -
BIA-51058-121 - 2020‐002317‐17 -
PHASE II Studies
BIA-51058-201 NCT04316143 2018-002448-10 -
BIA-51058-202 NCT06009185 2018-002796-18 -
BIA-51058-203 - 2021-001518-12 -

STUDY CODE CLINICALTRIALS.GOV EUDRACT PUBLICATIONS
PHASE I Studies
LTI-291-001 - 2017-002233-37 -
LTI-291-002 - 2017-002234-22 -
LTI-291-003 - 2017-004086-27 -
LTI-291-004 - 2018-000354-22 -
BIA-286156-105 - 2021-002546-32 -
BIA-286156-106 NCT05220072 2021-003018-38 -
BIA-286156-107 - 2021-002546-32 -
BIA-286156-109 - 2021-005896-37 -
BIA-286156-110 - - -
PHASE II Studies
BIA 28-6156 NCT05819359 2022-002477-29 -

×

You are now navigating away from the BIAL website.

BIAL takes responsibility for its website contents. By clicking “continue” below, you will be taken to an external website, beyond our responsibility.

CANCEL CONTINUE